Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,284 | -3,778 | -19,375 | -15,415 | -8,509 |
| Depreciation Amortization | 997 | 186 | 663 | 475 | 295 |
| Accounts payable and accrued liabilities | 1 | 999 | -48 | 227 | 61 |
| Other Working Capital | -212 | 682 | -686 | -642 | -446 |
| Other Operating Activity | 788 | -842 | 6,061 | 5,314 | 2,028 |
| Operating Cash Flow | $-6,710 | $-2,753 | $-13,385 | $-10,041 | $-6,571 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -5 | -91 | -85 | -55 |
| Net Acquisitions | N/A | N/A | 934 | 934 | 934 |
| Investing Cash Flow | $-22 | $-5 | $843 | $849 | $879 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,982 | 1,982 | 1,982 |
| Debt Repayment | -565 | -281 | -398 | -179 | -108 |
| Common Stock Issued | 9,991 | 8,051 | 8,384 | 8,239 | 2,288 |
| Financing Cash Flow | $9,426 | $7,770 | $9,968 | $10,042 | $4,162 |
| Beginning Cash Position | 7,600 | 7,600 | 10,174 | 10,174 | 10,174 |
| End Cash Position | 10,294 | 12,612 | 7,600 | 11,024 | 8,644 |
| Net Cash Flow | $2,694 | $5,012 | $-2,574 | $850 | $-1,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,710 | -2,753 | -13,385 | -10,041 | -6,571 |
| Capital Expenditure | -22 | -5 | -91 | -85 | -55 |
| Free Cash Flow | -6,732 | -2,758 | -13,476 | -10,126 | -6,626 |